The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving ...

The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with ...

Study findings show ChatGPT-4o provides accurate, complete, and trustworthy responses to patient-generated colorectal cancer ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent ...

The new executive order contains multiple provisions if pharmaceutical companies do not offer "most-favored nation" pricing ...

Pieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, ...

CK Wang, MD, chief medical officer of COTA, highlights how a lack of screening tools and declining ob-gyn pipeline can compound historical disparities seen in Black women's access to care.